|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Angiotensin II RIA Assay | Anti-Ustekinumab (Stelara®) ELISA | Pancreatic Polypeptide RIA Assay | Tenascin-C High Molecular Weight Variants ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27600 | RB320 US | TM09036 | RB316 US | 27751 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Radioimmunoassay (RIA) for the determination of angiotensin II in plasma (EDTA). For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Radioimmunoassay (RIA) for the determination Pancreatic Polypeptide (PP) in human serum. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Tenascin-C containing high molecular weight variants (Human Tenascin-C HMWV) in serum, plasma (heparin), or cell culture media. For research use only, not for use in diagnostic procedures. |
| Detection Target | Metanephrine / Normetanephrine | GPIHBP1 Autoantibody | sAPP Total | Glutamate | CA 242 |
| Sample Type | Urine | Serum, EDTA-plasma, heparin plasma, and post-heparin EDTA-plasma. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Urine, Serum, Blood Plasma | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 1.56 to 100.0 ng/mL | 4.7 to 150.0 pmol/L | Anti-Ustekinumab (Stelara®) | 6.25 to 200 pmol/L | 0.38 to 24 ng/mL |
| Sensitivity | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 0.001 U/mL | 0.06 ng/mL | 0.3 µg/mL | Inquire |
| Assay Time | 2 hours (incubation) | 18 hrs 15 mins (incubation) | 2 hour, 30 min. total incubation time. | 40 to 48 hrs 45 mins (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |